{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:19:07Z","timestamp":1790799547462,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672523"],"award-info":[{"award-number":["81672523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.phymed.2024.155426","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T20:51:59Z","timestamp":1707252719000},"page":"155426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Oridonin inhibits bladder cancer survival and immune escape by covalently targeting HK1"],"prefix":"10.1016","volume":"126","author":[{"given":"Shuangjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongze","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155426_bib0001","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1039\/C9CS00720B","article-title":"Advances in covalent kinase inhibitors","volume":"49","author":"Abdeldayem","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phymed.2024.155426_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41585-019-0263-6","article-title":"Competitive glucose metabolism as a target to boost bladder cancer immunotherapy","volume":"17","author":"Afonso","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.phymed.2024.155426_bib0003","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41586-019-1832-9","article-title":"KRAS4A directly regulates hexokinase 1","volume":"576","author":"Amendola","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2024.155426_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102565","article-title":"Ascorbate Plus Buformin in AML: a metabolic targeted Treatment","volume":"14","author":"Banella","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2024.155426_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3324\/haematol.2019.228478","article-title":"Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukemia","volume":"106","author":"Barrow","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.phymed.2024.155426_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.155426_bib0007","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nchembio.1810","article-title":"A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models","volume":"11","author":"Chan-Penebre","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.phymed.2024.155426_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4340950","article-title":"Oridonin promotes apoptosis and restrains the viability and migration of bladder cancer by impeding TRPM7 expression via the ERK and AKT signaling pathways","volume":"2021","author":"Che","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2024.155426_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s42255-022-00642-5","article-title":"HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma","author":"Chen","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phymed.2024.155426_bib0010","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/s41467-019-10042-1","article-title":"Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2024.155426_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","author":"Comperat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2024.155426_bib0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41389-022-00391-w","article-title":"NEDD9 sustains hexokinase expression to promote glycolysis","volume":"11","author":"Deneka","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.phymed.2024.155426_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3659714","article-title":"MCT4\/lactate promotes PD-L1 glycosylation in triple-negative breast cancer cells","volume":"2022","author":"Duan","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.phymed.2024.155426_bib0014","first-page":"9264","article-title":"Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer","volume":"8","author":"Gao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.phymed.2024.155426_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41590-020-00829-6","article-title":"NF-kappaB-inducing kinase maintains T cell metabolic fitness in antitumor immunity","volume":"22","author":"Gu","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phymed.2024.155426_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100077","article-title":"Hexokinases in cancer and other pathologies","volume":"2","author":"Guo","year":"2023","journal-title":"Cell Insight"},{"key":"10.1016\/j.phymed.2024.155426_bib0017","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2024.155426_bib0018","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2024.155426_bib0019","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41418-021-00804-0","article-title":"YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect","volume":"28","author":"Hou","year":"2021","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.phymed.2024.155426_bib0020","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.O111.016253","article-title":"Rapid identification of monospecific monoclonal antibodies using a human proteome microarray","volume":"11","author":"Jeong","year":"2012","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.phymed.2024.155426_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118669","article-title":"A pan-cancer analysis of molecular characteristics and oncogenic role of hexokinase family genes in human tumors","volume":"264","author":"Jiang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2024.155426_bib0022","article-title":"Artesunate inhibits the development of esophageal cancer by targeting HK1 to reduce glycolysis levels in areas with zinc deficiency","volume":"12","author":"Jin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2024.155426_bib0023","article-title":"Oridonin: a review of its pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155426_bib0024","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13046-023-02625-0","article-title":"HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma","volume":"42","author":"Liu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155426_bib0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13046-022-02500-4","article-title":"Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer","volume":"41","author":"Liu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155426_bib0026","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-022-00831-5","article-title":"METTL14-mediated N(6)-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma","volume":"20","author":"Liu","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phymed.2024.155426_bib0027","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13020-019-0270-9","article-title":"Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine","volume":"14","author":"Luo","year":"2019","journal-title":"Chin. Med."},{"key":"10.1016\/j.phymed.2024.155426_bib0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phymed.2024.155426_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ccell.2019.12.009","article-title":"Sticking it to KRAS: covalent inhibitors enter the clinic","volume":"37","author":"McCormick","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2024.155426_bib0030","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2024.155426_bib0031","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrurol.2015.111","article-title":"Targeting glycogen metabolism in bladder cancer","volume":"12","author":"Ritterson Lew","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.phymed.2024.155426_bib0032","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.drudis.2022.05.017","article-title":"The development of small-molecule inhibitors targeting hexokinase 2","volume":"27","author":"Shan","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phymed.2024.155426_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2016.03.005","article-title":"Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds","volume":"40-41","author":"Shanmugam","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.phymed.2024.155426_bib0034","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155426_bib0035","doi-asserted-by":"crossref","first-page":"17471","DOI":"10.1074\/jbc.RA119.009801","article-title":"A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3","volume":"294","author":"Shen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155426_bib0036","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.21.02928","article-title":"Therapy for muscle-invasive urothelial carcinoma: controversies and dilemmas","volume":"40","author":"Sonpavde","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.155426_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104891","article-title":"Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors","volume":"112","author":"Sun","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phymed.2024.155426_bib0038","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41556-022-00925-9","article-title":"The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness","volume":"24","author":"Thomas","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2024.155426_bib0039","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/d41573-020-00125-w","article-title":"Harnessing the PERx of covalent protein drugs","volume":"19","author":"Villanueva","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.155426_bib0040","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1158\/0008-5472.CAN-18-2799","article-title":"An HK2 antisense oligonucleotide induces synthetic lethality in HK1(-)HK2(+) multiple myeloma","volume":"79","author":"Xu","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155426_bib0041","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fonc.2019.00769","article-title":"Oridonin sensitizes cisplatin-induced apoptosis via AMPK\/Akt\/mTOR-dependent autophagosome accumulation in A549 cells","volume":"9","author":"Yang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2024.155426_bib0042","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10787-019-00644-y","article-title":"Oridonin attenuates carrageenan-induced pleurisy via activation of the KEAP-1\/Nrf2 pathway and inhibition of the TXNIP\/NLRP3 and NF-kappaB pathway in mice","volume":"28","author":"Yang","year":"2020","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.phymed.2024.155426_bib0043","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1073\/pnas.1521316112","article-title":"Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.phymed.2024.155426_bib0044","doi-asserted-by":"crossref","first-page":"13732","DOI":"10.1038\/ncomms13732","article-title":"c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2024.155426_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105367","article-title":"Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis","volume":"164","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2024.155426_bib0046","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3892\/mmr.2016.6008","article-title":"Oridonin promotes G2\/M arrest in A549 cells by facilitating ATM activation","volume":"15","author":"Zheng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phymed.2024.155426_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202270012","article-title":"Oridonin inhibits SARS-CoV-2 by targeting Its 3C-like protease","volume":"2","author":"Zhong","year":"2022","journal-title":"Small. Sci."},{"key":"10.1016\/j.phymed.2024.155426_bib0048","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1081\/DMR-200028812","article-title":"Drug bioactivation, covalent binding to target proteins and toxicity relevance","volume":"37","author":"Zhou","year":"2005","journal-title":"Drug Metab. Rev."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:55:24Z","timestamp":1760554524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":48,"alternative-id":["S0944711324000916"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155426","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oridonin inhibits bladder cancer survival and immune escape by covalently targeting HK1","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155426"}}